P1122: EFFICACY OF ALPELISIB IN PI3K-DRIVEN LANGERHANS CELL HISTIOCYTOSIS

por Mazor, R., Durham, B., Abdel-Wahab, O., Diamond, E., Itchaki, G., Ben-Sasson, M., Hershkovitz-Rokah, O., Shpilberg, O.
Publicado 2022

Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium

por Tefferi, A, Abdel-Wahab, O, Cervantes, F, Crispino, J D, Finazzi, G, Girodon, F, Gisslinger, H, Gotlib, J, Kiladjian, J-J, Levine, R L, Licht, J D, Mullally, A, Odenike, O, Pardanani, A, Silver, R T, Solary, E, Mughal, T
Publicado 2011

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

por Tefferi, A, Lasho, T L, Abdel-Wahab, O, Guglielmelli, P, Patel, J, Caramazza, D, Pieri, L, Finke, C M, Kilpivaara, O, Wadleigh, M, Mai, M, McClure, R F, Gilliland, D G, Levine, R L, Pardanani, A, Vannucchi, A M
Publicado 2010

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia

por Santini, V, Allione, B, Zini, G, Gioia, D, Lunghi, M, Poloni, A, Cilloni, D, Sanna, A, Masiera, E, Ceccarelli, M, Abdel-Wahab, O, Terenzi, A, Angelucci, E, Finelli, C, Onida, F, Pelizzari, A, Ferrero, D, Saglio, G, Figueroa, M, Levis, A
Publicado 2018

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer

por Kämpjärvi, K, Mäkinen, N, Kilpivaara, O, Arola, J, Heinonen, H-R, Böhm, J, Abdel-Wahab, O, Lehtonen, H J, Pelttari, L M, Mehine, M, Schrewe, H, Nevanlinna, H, Levine, R L, Hokland, P, Böhling, T, Mecklin, J-P, Bützow, R, Aaltonen, L A, Vahteristo, P
Publicado 2012